お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は腹膜癌市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは腹膜癌の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の腹膜癌市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは腹膜癌のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に腹膜癌市場を分類しています。本研究に含まれる主な企業は：AstraZeneca、GlaxoSmithKline、Oxford BioMedica、Millennium Pharmaceuticals、Novartis、Bayer、Incyte、EntreMed、Oncolytics Biotech、Synta Pharmaceuticals、Oasmia Pharmaceutical

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Surgery
    Chemotherapy (Anticancer Drugs)
    Radiotherapy (High-Energy Rays)

用途別の市場セグメント：
    Cancer Research Centers
    Cancer Hospital
    Surgical Centers
    Clinics

本レポートの詳細内容
世界の腹膜癌市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、腹膜癌タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の腹膜癌収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の腹膜癌市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、腹膜癌市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

腹膜癌のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：腹膜癌のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：腹膜癌の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章腹膜癌企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：腹膜癌の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：腹膜癌の主要企業の概要を提供し、製品の説明と仕様、腹膜癌の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.

Market Analysis and Insights: Global Peritoneal Cancer Market
The global Peritoneal Cancer market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
Report Covers:
This report presents an overview of global market for Peritoneal Cancer market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Peritoneal Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peritoneal Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Peritoneal Cancer revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peritoneal Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peritoneal Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca, GlaxoSmithKline, Oxford BioMedica, Millennium Pharmaceuticals, Novartis, Bayer, Incyte, EntreMed and Oncolytics Biotech, etc.

Market Segmentation
By Company
    AstraZeneca
    GlaxoSmithKline
    Oxford BioMedica
    Millennium Pharmaceuticals
    Novartis
    Bayer
    Incyte
    EntreMed
    Oncolytics Biotech
    Synta Pharmaceuticals
    Oasmia Pharmaceutical

Segment by Type
    Surgery
    Chemotherapy (Anticancer Drugs)
    Radiotherapy (High-Energy Rays)

Segment by Application
    Cancer Research Centers
    Cancer Hospital
    Surgical Centers
    Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Peritoneal Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peritoneal Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peritoneal Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Peritoneal Cancer Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Surgery
    Table 3. Key Players of Chemotherapy (Anticancer Drugs)
    Table 4. Key Players of Radiotherapy (High-Energy Rays)
    Table 5. Global Peritoneal Cancer Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Peritoneal Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Peritoneal Cancer Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Peritoneal Cancer Market Share by Region (2019-2024)
    Table 9. Global Peritoneal Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Peritoneal Cancer Market Share by Region (2025-2030)
    Table 11. Peritoneal Cancer Market Trends
    Table 12. Peritoneal Cancer Market Drivers
    Table 13. Peritoneal Cancer Market Challenges
    Table 14. Peritoneal Cancer Market Restraints
    Table 15. Global Peritoneal Cancer Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Peritoneal Cancer Revenue Share by Players (2019-2024)
    Table 17. Global Top Peritoneal Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2023)
    Table 18. Global Peritoneal Cancer Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Peritoneal Cancer Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Peritoneal Cancer, Headquarters and Area Served
    Table 21. Global Key Players of Peritoneal Cancer, Product and Application
    Table 22. Global Key Players of Peritoneal Cancer, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Peritoneal Cancer Revenue Market Share by Type (2019-2024)
    Table 26. Global Peritoneal Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Peritoneal Cancer Revenue Market Share by Type (2025-2030)
    Table 28. Global Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Peritoneal Cancer Revenue Share by Application (2019-2024)
    Table 30. Global Peritoneal Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Peritoneal Cancer Revenue Share by Application (2025-2030)
    Table 32. North America Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Peritoneal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Peritoneal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Peritoneal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Peritoneal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Peritoneal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Peritoneal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Peritoneal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Peritoneal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Peritoneal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Peritoneal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Peritoneal Cancer Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Peritoneal Cancer Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Peritoneal Cancer Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Peritoneal Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Peritoneal Cancer Market Size by Country (2025-2030) & (US$ Million)
    Table 64. AstraZeneca Company Details
    Table 65. AstraZeneca Business Overview
    Table 66. AstraZeneca Peritoneal Cancer Product
    Table 67. AstraZeneca Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 68. AstraZeneca Recent Developments
    Table 69. GlaxoSmithKline Company Details
    Table 70. GlaxoSmithKline Business Overview
    Table 71. GlaxoSmithKline Peritoneal Cancer Product
    Table 72. GlaxoSmithKline Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 73. GlaxoSmithKline Recent Developments
    Table 74. Oxford BioMedica Company Details
    Table 75. Oxford BioMedica Business Overview
    Table 76. Oxford BioMedica Peritoneal Cancer Product
    Table 77. Oxford BioMedica Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 78. Oxford BioMedica Recent Developments
    Table 79. Millennium Pharmaceuticals Company Details
    Table 80. Millennium Pharmaceuticals Business Overview
    Table 81. Millennium Pharmaceuticals Peritoneal Cancer Product
    Table 82. Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 83. Millennium Pharmaceuticals Recent Developments
    Table 84. Novartis Company Details
    Table 85. Novartis Business Overview
    Table 86. Novartis Peritoneal Cancer Product
    Table 87. Novartis Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 88. Novartis Recent Developments
    Table 89. Bayer Company Details
    Table 90. Bayer Business Overview
    Table 91. Bayer Peritoneal Cancer Product
    Table 92. Bayer Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 93. Bayer Recent Developments
    Table 94. Incyte Company Details
    Table 95. Incyte Business Overview
    Table 96. Incyte Peritoneal Cancer Product
    Table 97. Incyte Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 98. Incyte Recent Developments
    Table 99. EntreMed Company Details
    Table 100. EntreMed Business Overview
    Table 101. EntreMed Peritoneal Cancer Product
    Table 102. EntreMed Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 103. EntreMed Recent Developments
    Table 104. Oncolytics Biotech Company Details
    Table 105. Oncolytics Biotech Business Overview
    Table 106. Oncolytics Biotech Peritoneal Cancer Product
    Table 107. Oncolytics Biotech Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 108. Oncolytics Biotech Recent Developments
    Table 109. Synta Pharmaceuticals Company Details
    Table 110. Synta Pharmaceuticals Business Overview
    Table 111. Synta Pharmaceuticals Peritoneal Cancer Product
    Table 112. Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 113. Synta Pharmaceuticals Recent Developments
    Table 114. Oasmia Pharmaceutical Company Details
    Table 115. Oasmia Pharmaceutical Business Overview
    Table 116. Oasmia Pharmaceutical Peritoneal Cancer Product
    Table 117. Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2019-2024) & (US$ Million)
    Table 118. Oasmia Pharmaceutical Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peritoneal Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Peritoneal Cancer Market Share by Type: 2023 VS 2030
    Figure 3. Surgery Features
    Figure 4. Chemotherapy (Anticancer Drugs) Features
    Figure 5. Radiotherapy (High-Energy Rays) Features
    Figure 6. Global Peritoneal Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Peritoneal Cancer Market Share by Application: 2023 VS 2030
    Figure 8. Cancer Research Centers Case Studies
    Figure 9. Cancer Hospital Case Studies
    Figure 10. Surgical Centers Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. Peritoneal Cancer Report Years Considered
    Figure 13. Global Peritoneal Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Peritoneal Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Peritoneal Cancer Market Share by Region: 2023 VS 2030
    Figure 16. Global Peritoneal Cancer Market Share by Players in 2023
    Figure 17. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Peritoneal Cancer Revenue in 2023
    Figure 19. North America Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Peritoneal Cancer Market Share by Type (2019-2030)
    Figure 21. North America Peritoneal Cancer Market Share by Application (2019-2030)
    Figure 22. North America Peritoneal Cancer Market Share by Country (2019-2030)
    Figure 23. United States Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Peritoneal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Peritoneal Cancer Market Share by Type (2019-2030)
    Figure 27. Europe Peritoneal Cancer Market Share by Application (2019-2030)
    Figure 28. Europe Peritoneal Cancer Market Share by Country (2019-2030)
    Figure 29. Germany Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Peritoneal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Peritoneal Cancer Market Share by Type (2019-2030)
    Figure 37. China Peritoneal Cancer Market Share by Application (2019-2030)
    Figure 38. Asia Peritoneal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Peritoneal Cancer Market Share by Type (2019-2030)
    Figure 40. Asia Peritoneal Cancer Market Share by Application (2019-2030)
    Figure 41. Asia Peritoneal Cancer Market Share by Region (2019-2030)
    Figure 42. Japan Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Peritoneal Cancer Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Peritoneal Cancer Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Peritoneal Cancer Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Peritoneal Cancer Market Share by Country (2019-2030)
    Figure 52. Brazil Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Peritoneal Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. AstraZeneca Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 60. Oxford BioMedica Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 61. Millennium Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 62. Novartis Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 63. Bayer Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 64. Incyte Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 65. EntreMed Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 66. Oncolytics Biotech Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 67. Synta Pharmaceuticals Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 68. Oasmia Pharmaceutical Revenue Growth Rate in Peritoneal Cancer Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed